Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MIGLUSTAT GEN.ORPH 100 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MIGLUSTAT GEN.ORPH 100 MG CAPSULAS DURAS EFG

Approved

STANDARD

MIGLUSTAT GEN.ORPH 100 MG CAPSULAS DURAS EFG

Gen.Orph S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 24, 2020
Approval ID: cd59671437fb7c3d
Company: Gen.Orph S.A.S.
Type: Standard

Approval Details

Approval Id: cd59671437fb7c3d
Drug Cima Aemps Name: MIGLUSTAT GEN.ORPH 100 MG CAPSULAS DURAS EFG
Register Number: 1171232001
Holder Company Name: Gen.Orph S.A.S.
Marketing Company Name: Biojam España S.L.
Authorization Date: 2020-07-24
Dosage Form: CÁPSULA DURA
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Gen.Orph S.A.S.

Active Ingredients

MIGLUSTAT

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 24, 2020

Approval ID

cd59671437fb7c3d

Type

Standard

Back to CIMA-AEMPS Approvals